HR 7528119th CongressIn Committee
GAP Supply Act
Standard Summary
Balanced plain-English summary
The GAP Supply Act would amend section 503B of the Federal Food, Drug, and Cosmetic Act to give outsourcing facilities a short-term period to continue compounding and distributing drugs after a drug is in shortage. Specifically, it would replace certain timing references with a 180-calendar-day window to help mitigate drug shortages and maintain market supply.
Key Points
- 1Amends section 503B of the Federal Food, Drug, and Cosmetic Act.
- 2Creates a 180-calendar-day tail period for outsourcing facilities after a drug is in shortage.
- 3Changes timing language in two provisions from 'at the time' to 'within 180 calendar days'.
- 4Aims to help mitigate drug shortages and maintain supply.
- 5Referred to the House Committee on Energy and Commerce.
Impact Areas
PatientsHospitals and health systemsOutsourcing facilitiesDrug supply chainFood and Drug Administration
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026